Immunopathogenesis in SARS-CoV-2 and Mycobacterium tuberculosis: The danger of overlapping crises

Front Pharmacol. 2022 Nov 16:13:1065124. doi: 10.3389/fphar.2022.1065124. eCollection 2022.

¹ Department of Virology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
² Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

No abstract available

Keywords: COVID; Mycobacterium tuberculosis (M Tuberculosis); biomarkers (MESH D015415); coinfections; treatment regimens.